Advertisement

Topics

Sequella, Inc. Company Profile

00:48 EST 22nd November 2017 | BioPortfolio

Sequella is a clinical stage biopharmaceutical company focused on commercializing improved treatments for infectious diseases. The company leverages its global influence, R&D platforms and infectious disease expertise to proactively address emerging health threats. Through focused execution, clear commercialization pathways, and strategic partnerships, Sequella intends to commercialize a broad product portfolio designed to treat global health threats with significant market opportunity.


News Articles [3 Associated News Articles listed on BioPortfolio]

Sequella Inc Medical Equipment Deals and Alliances Profile. [Report Updated: 20072017] Prices from USD $250

SummarySequella Inc Sequella is a clinicalstage pharmaceutical company that develops and commercializes small molecule and natural productbased therapeutics for the treatment of infectious diseases. T...

Sequella Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 22082017] Prices from USD $250

SummarySequella Inc Sequella is a clinicalstage pharmaceutical company that develops and commercializes small molecule and natural productbased therapeutics for the treatment of infectious diseases. T...

Duodenal Ulcer Pipeline Insight, 2017 [Report Updated: 10072017] Prices from USD $1250

DelveInsight's, Duodenal Ulcer Pipeline Insights, 2017, report provides comprehensive insights about pipeline drugs across this Duodenal Ulcer. The key objective of the report is to establish the und...

Drugs and Medications [0 Results]

None

PubMed Articles [1 Associated PubMed Articles listed on BioPortfolio]

The role of hepatocyte growth factor in corneal wound healing.

Hepatocyte growth factor (HGF) is a glycoprotein produced by mesenchymal cells and operates as a key molecule for tissue generation and renewal. During corneal injury, HGF is primarily secreted by str...

Clinical Trials [0 Results]

None

Companies [3 Associated Companies listed on BioPortfolio]

Sequella Incorporated

Sequella, Inc. is poised to become a biotechnology leader in the fight against global infectious diseases. Founded in 1997 by Drs. Nacy and Einck, Sequella is developing novel therapeutics, diagnosti...

Sequella, Inc.

Sequella is a clinical stage biopharmaceutical company focused on commercializing improved treatments for infectious diseases. The company leverages its global influence, R&D platforms and infectious ...

Sequella Inc.

Sequella is a clinical stage pharmaceutical company focused on identifying, developing, and commercializing novel antibiotics to treat infectious diseases, particularly those for ...

More Information about "Sequella, Inc." on BioPortfolio

We have published hundreds of Sequella, Inc. news stories on BioPortfolio along with dozens of Sequella, Inc. Clinical Trials and PubMed Articles about Sequella, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Sequella, Inc. Companies in our database. You can also find out about relevant Sequella, Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Public Health
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...

Infectious-diseases
Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...


Corporate Database Quicklinks



Searches Linking to this Company Record